“Adverse Effects and Adherence to Treatment of Rifampicin 4 months Vs Isoniazid 6 months for Latent Tuberculosis”. 2011. Swiss Medical Weekly 141 (3334): w13240. https://doi.org/10.4414/smw.2011.13240.